This Viewpoint discusses changes proposed by the US Department of Health and Human Services’ Office of Research Integrity that would shift control of research misconduct proceedings from institutional oversight to federal authority.
No takes yet. Share an insight, caveat, or question.
Caron et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: